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RENAL CELL CARCINOMA
ITWENTY－THREE YEARS OF EXPERIENCE AT
   KYOTO UNIVERSITY HOSPITAL
Takuo lwAsAKi， Juichi KAwAMuRA and Osamu Yos｝liDA
 From the DePartment of Urolog2， Facult2 ・of Medicine・， ・K］olo Universitl
               （Director： Prof． O． YoShida， M． D．）
    One．hundred and twenty－three cases of renal cell carcinoma， treated at Department of’Urology，
Kyoto University Hospital during January 1955 through’ December 1977 were reyiewed．
    1．As。th6 patients．．were classified according to Holland，s classi丘cation， twelv6 cases were stage
I， nineteen cases Sta’№?H？ fifty－thrce cases stage III， twenty－two cases stage IV， and se／venteen cases
unclassified．
    2． ’Overall relative survival tate qt one year， three year， five year， ten・year were 720／o， 500／o，’
460／．， 34’O／．．・respectively．
    3． The most comrnon sympt6m was macros． copic hematuria， and followed by pain， fever， weight
loss， fatigue and plapable mass．
    4． Relaf’ive sUrvival rate of the patients who sh’ow．ed．macroscopic hematuria was better than
that of the patients who did not show macroscopic hematuria． Relative survival rate of the patients
who ’р奄?not have palpable abdominal mass was better than that of the patients who had， palpable
abdoMinal rnass，． The presence of・pain or fever did not alter the survival rate．
    5． As ．fQr the laboratory findings， elevation of erythr．ocyte sedimentation rate was most common，
飼1・w・dby p・・iti・6．b－rcacti・・p・・t・in，．¢ICY・ti・n・f・lk・lin・ph・・ph・t・・e valu・，、．・1・v・ti・n・f l・dt圭・
dehydrogenase value， and serum Ca elevation．
    6． The relative survival rate of the patients who showed normal erythrocyte sedimentation．
rate or alkaline phosphatase． Value were． better than．the patients who showed abnoraml erythrocyte’
sedimentation rate or alkaline phosphatase value． The highet the erythrocyte sedimentation rate
showed， the poorer the ．relative survival’窒≠狽?of the patient．
    7．The site of distant血etastasis was most common in lung， fbUowed by bone， lymph n6すe and
liver． The patients with bone metastasis lived loriger than the patients with lung Metastasis．
8．No remarkψ1e difference．was scen between the survival rate of the patients treated by nephrcc－
tomy alene and nephrectomY ’Plus adjuvant therapy．
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Fig． 1． Distribution according to age ＆ sex in
















Table 1． Clinical manifestations in 123 renal cell carcinoma patients．
No． of pts． Ce／e）
Positive Negative
Gross haernaturia一・・……・・一・・・・…一…・一・





















Table 2． 1．aboratory findings in 12S renal cell carcinoma patients．
Number of patients ｛e／oJ
ESR…一・一・…一・一・一一一…一・・一一一一・ elevated 63C69．2｝ ； norma｝ 28C508）
CRP一・・…：一一一一一・…一・一一・一一・・一一・ positive 21（46．7） ； negative 24｛55．3）
Alkoline phosphataset一・ elevoted 18C50，0）；normol 42t70．0｝
Serum calcium・一一H一”””・一 elevoted 2（ 5．6｝ ； normal 55｛96．4｝



























Table． 3． Distant metastases detected
     preoperatively in 123 renal
     cell carcinoma patints．
Number of patients CO／o）
Lung 一一一・一一・一一・；・一一…一一一一・一一一一一・一・一・一一一一一一・・…一一 1 3 ｛ lb．6）
Bone一・・一一…一・一一一・一・一一・一一一・・一・一一・一一一一・一一一・一一一一・ 7｛ 5．7）
  Spine一一一一一一・4
  Clavide一一一一 1
  Talus一一一一一一一 l
  Scapula一一一一 I
  Humerus・一一一 l
Lymph node｛Virchowもnode｝一…2臼．6｝
Live r “一n一’…”H’一’一’一一’’””””’H’・・一一一・一・・一一・一一一一 1 ｛ O．8）
56・5％，骨30・4％，リンパ節8・7％，肝4．3％の順であ
った．
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Fig．3． Relative survival rate vs． staging of
    rena星cell carcinoma in 106 renal



























れ、stage別に症例数を算出し， stage I， stage IIを
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1 3   5  YEARS 10
Fig． 4． Relative survival rate vs． clinical
    manifestations in 106 renal cell
    carcinoma patients （n） ＝＝No． of pts．
stage別に見ると， stage Iはなく，．stage II l例，
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Fig， 5． Relative survival rate vs． erythrocyte
    sedimentation rate （ESR） or alkaline
    phosphatase．



















min 20～H5mg，その後merphillin 725mg， endoxan
900 一一一 1200 mg， mitomycin C 6 一一 8 mg 十 endoxan
lOO mgの併用療法や， METVFC療法（mitomycin，
endoxan， toyornycin， vincristine，5－Fu， cylosideの併
用），actinomycin D，5－Fuなどが使用されている．






































     o        l    5    5 10
                YeaTs
Fig．6． In亡erval between onse亡of symptoms＆surgery vs． relative survival rate．
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Table 4． Mode of treatment of 123 renal cell carcinoma patients
No・ of potients
i） Nephrectomy performed
  l） Nephrectomy only
  旧Nephredomy十Chemolheropy
  111 ） Nephrectorny 十 Radiation
  IV） Nephrectomy 十 Chemotherapy 十 Radiation
  V ） Nephrectomy 十 Hormone therapy
 Vl ） Nephrectomy 十 Hormone therapy 十 Chemotherapy
2） Nephrectomy not performed
  l） Chemotherapy only
  旧Hormone therapy only
  ． lll ） Chemotherapy 十 Radiation
  IV） Embolization ofily
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Table 5． Distribution of patients treated nephrecto－
     my alone or nephrectomy plus adjuvant
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Table 6．Survival of renal cell carcinoma patients
with lung er bone metastasis
Lung metastasis ｛n＝9）
Surviva12 month一；一 57 month
 C mean i4 month ）
Bone rnetostasis ｛n＝6）
Surviva15 month 一一一一 64 month











































































































































































































































































類したところ，stage I 12例， stage II 19例， stage
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